Increasing evidence suggests that upregulation of immune checkpoints, such as the programmed cell death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD1) pathway, is an important way for tumor cells to achieve immune evasion (Hayashi H et al., 2024). The gene discussed is PDCD1; the disease is neoplasm.